Listen the anecdotal evidence is GREAT, however, that will not drive S.O.C for cardiac surgery or sepsis. Anecdotal evidence will not yield sales in $10M per quarter, which is the valuation this is getting right now.
$40M in sales at 30% net profit margin (this is after tax, interest expense, etc) = $12M in net income
$12M earnings / 30M shares fully diluted = $0.40 a share x 20 P/E multiple = $8.00 per share.
So right now if the company was doing $40M in sales (just about >10x what they are currently doing) the P/E ratio would be 20!!!
People say this stock is cheap, is it really?!?!?!?!???
at $4M in sales which is 10x less than what I just said above the P/E is 200!!!
News 
Market Data 
Discover 
AI
